A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA)
Part of paid clinical trials in Fountain Valley, California.
- Sponsor
- Incyte Corporation
- Study ID
- NCT04896385
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Ruxolitinib cream — DRUGRuxolitinib cream is a topical formulation applied as a thin film to affected areas.
- Vehicle Cream — DRUGVehicle cream is matching in appearance to ruxolitinib cream and is to be applied in the same manner as ruxolitinib cream.
Study Details
The purpose of the study is to evaluate the Mechanism Of Action (MOA) of ruxolitinib cream in vitiligo by assessing the change in biomarkers.
Key Dates
- Start date
- Jun 23, 2021
- Status verified
- Aug 2025
- Primary completion
- Nov 17, 2022
- Completion
- Jul 10, 2023
Study Design
- Enrollment
- 60 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: Ruxolitinib creamRuxolitinib cream will be administered twice a day (BID) for 24 weeks
- Placebo Comparator: Vehicle CreamVehicle cream is matching in appearance to ruxolitinib cream and is to be applied in the same manner as ruxolitinib cream.
Primary Outcome Measure
Percentage Change From Baseline in Chemokine (C-X-C Motif) Ligand 10 (CXCL10), an Immune Biomarker, at Week 4, Week 12, and Week 24 [ Time Frame: Baseline; Week 4, Week 12, and Week 24 ]
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| First Oc Dermatology | Fountain Valley | California | 92708 | - |
| UC Irvine | Irvine | California | 92697 | - |
| George Washington Medical Faculty Associates | Washington D.C. | District of Columbia | 20037 | - |
| Suny Downstate Medical Center | Brooklyn | New York | 11203 | - |
| Mount Sinai Hospital | New York | New York | 10029 | - |
| Dermatology Specialists of Spokane | Spokane | Washington | 99202 | - |
Find similar trials in Fountain Valley, CA
Related Studies
- A Study of LY4005130 in Adult Participants With Non-Segmental VitiligoPHASE2 · Recruiting · Eli Lilly and Company · Phoenix, Arizona
- The Gut and Skin Microbiome in Vitiligo Disease ProgressionRecruiting · Northwestern University · Chicago, Illinois